TransCode Therapeutics Reports Publication Of U.S. Patent Application Titled, "Nanoparticles And Template Directed RIG-I Agonist Precursor Compositions And Uses Thereof For Cancer Therapy"
TransCode Therapeutics Reports Publication Of U.S. Patent Application Titled, "Nanoparticles And Template Directed RIG-I Agonist Precursor Compositions And Uses Thereof For Cancer Therapy"
TransCode Therapeutics報告了題爲 “納米顆粒和模板定向RIG-I激動劑前體組合物及其在癌症治療中的用途” 的美國專利申請的發佈
TransCode Therapeutics Reports Publication Of U.S. Patent Application Titled, "Nanoparticles And Template Directed RIG-I Agonist Precursor Compositions And Uses Thereof For Cancer Therapy"
TransCode Therapeutics報告了題爲 “納米顆粒和模板定向RIG-I激動劑前體組合物及其在癌症治療中的用途” 的美國專利申請的發佈
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。